RISK FACTOR FOR MYOCARDIAL INFARCTION IN TRANSURETHRAL RESECTION OF PROSTATE?
- 7 October 1989
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 334 (8667) , 859-860
- https://doi.org/10.1016/s0140-6736(89)93016-x
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Mortality and Reoperation after Open and Transurethral Resection of the Prostate for Benign Prostatic HyperplasiaNew England Journal of Medicine, 1989
- An Assessment of Prostatectomy for Benign Urinary Tract ObstructionJAMA, 1988
- Prostatectomy: Patients' Perception and Long‐term Follow‐UPBritish Journal of Urology, 1988
- Fluid Absorption During Urological EndoscopyBritish Journal of Urology, 1987
- Medical Treatment of Acromegaly with SMS 201-995, a Somatostatin Analog: A Comparison with Bromocriptine*Journal of Clinical Endocrinology & Metabolism, 1987
- A Comparison among the Growth Hormone-Lowering Effects in Acromegaly of the Somatostatin Analog SMS 201-995, Bromocriptine, and the Combination of Both DrugsJournal of Clinical Endocrinology & Metabolism, 1986
- Hemodynamic changes during prostatectomy in cardiac patientsCritical Care Medicine, 1982
- Prostatectomy: Its safety in an Australian teaching hospitalBritish Journal of Surgery, 1977
- Observations on Cardiac Output, Blood Volume, Central Venous Pressure, Fluid and Electrolyte Changes in Patients Undergoing Transurethral ProstatectomyJournal of Urology, 1970
- Clinically Unrecognized Myocardial Infarction Following SurgeryNew England Journal of Medicine, 1961